| Page 1009 | Kisaco Research

With New York, Colorado and California as notable examples, the proliferation of state level data privacy regimes is imposing various restrictions on how data can be used. Could PETs simultaneously generate value and minimize regulatory friction?

  • Determining how PETs can comply with disparate regulations across the United States
  • Understanding the regulatory perspective on PETs and why there has been a global governmental push for implementation
  • Assessing which considerations need to be made to avoid regulatory challenge especially when it comes to innovative data sharing initiatives

Author:

Orrie Dinstein

Global Chief Privacy Officer
Marsh McLennan
... read more

Orrie Dinstein

Global Chief Privacy Officer
Marsh McLennan

Author:

Nada Bseikri

Assistant General Counsel, Data Privacy & Regulation
Robinhood
... read more

Nada Bseikri

Assistant General Counsel, Data Privacy & Regulation
Robinhood

Author:

Shashi Gowda

CEO
Devr

Shashi Gowda is CEO and co-founder of Devr and a member of its board of directors.  A seasoned technology leader and entrepreneur, Shashi brings over 20 years of experience in the telecommunications, big data and emerging tech industries.

 

Devr provides tools for enterprises to design and orchestrate data privacy, enabling rich open ecosystems for data monetization with continuous compliance.

 

Shashi champions advances in digital transformation, data privacy and continuous compliance using emerging technologies such as Blockchain and AI.  He is passionate about bringing technologies into highly regulated industries which enable them to innovate with data, in an era of growing privacy concerns, regulatory complexity, and high costs of non-compliance.

 

Before founding Devr, Shashi was CTO of Virtual Control and supported the sale of its AI and ML solutions to Agilent Technologies.  Prior to that, Shashi held various technology design and leadership roles, at both corporates and at early-stage companies, and has worked across Asia, Europe, and the US.

 

Shashi earned his bachelor’s degree in bio-medical engineering from Boston University.

... read more

Shashi Gowda

CEO
Devr

Shashi Gowda is CEO and co-founder of Devr and a member of its board of directors.  A seasoned technology leader and entrepreneur, Shashi brings over 20 years of experience in the telecommunications, big data and emerging tech industries.

 

Devr provides tools for enterprises to design and orchestrate data privacy, enabling rich open ecosystems for data monetization with continuous compliance.

 

Shashi champions advances in digital transformation, data privacy and continuous compliance using emerging technologies such as Blockchain and AI.  He is passionate about bringing technologies into highly regulated industries which enable them to innovate with data, in an era of growing privacy concerns, regulatory complexity, and high costs of non-compliance.

 

Before founding Devr, Shashi was CTO of Virtual Control and supported the sale of its AI and ML solutions to Agilent Technologies.  Prior to that, Shashi held various technology design and leadership roles, at both corporates and at early-stage companies, and has worked across Asia, Europe, and the US.

 

Shashi earned his bachelor’s degree in bio-medical engineering from Boston University.

Privacy- enhancing technologies are revolutionising the way we approach and use highly sensitive data. This panel will explore why capitalising on these developments is essential to drive value moving forwards.

  • Establishing how PETs can deliver additional business value through unlocking previously inaccessible data
  • Practical first-hand examples of successfully identifying relevant use cases, establishing proof of concept and deriving the benefits.
  • What the ROI of PETs will look like and how to measure that after implementation

Author:

Andrew Bjerken

Vice President, Head of Global Privacy
Marriot Vacations Worldwide
... read more

Andrew Bjerken

Vice President, Head of Global Privacy
Marriot Vacations Worldwide

Author:

Nishant Bhajaria

Director of Privacy Engineering, Architecture and Analytics
Uber
... read more

Nishant Bhajaria

Director of Privacy Engineering, Architecture and Analytics
Uber

Author:

Nick New

Founder
Optalysys

Founded Optalysys in 2013 with twenty years experience in Fourier optical processing, having previously spun Cambridge Correlators Ltd. out of the University of Cambridge from technology developed during PhD in Optical Pattern Recognition.

... read more

Nick New

Founder
Optalysys

Founded Optalysys in 2013 with twenty years experience in Fourier optical processing, having previously spun Cambridge Correlators Ltd. out of the University of Cambridge from technology developed during PhD in Optical Pattern Recognition.

Author:

Dr. Walden “Wally” Rhines

President & CEO
Cornami

WALDEN C. RHINES is President & CEO of Cornami. He is also CEO Emeritus of Mentor, a Siemens business, focusing on external communications and customer relations. He was previously CEO of Mentor Graphics for 23 years and Chairman of the Board for 17 years. During his tenure at Mentor, revenue nearly quadrupled and market value of the company increased 10X.

Prior to joining Mentor Graphics, Dr. Rhines was Executive Vice President, Semiconductor Group, responsible for TI’s worldwide semiconductor business. During his 21 years at TI, he was President of the Data Systems Group and held numerous other semiconductor executive management positions.

Dr. Rhines has served on the boards of Cirrus Logic, QORVO, TriQuint Semiconductor, Global Logic and as Chairman of the Electronic Design Automation Consortium (five two-year terms) and is currently a director. He is also a board member of the Semiconductor Research Corporation and First Growth Children & Family Charities. He is a Lifetime Fellow of the IEEE and has served on the Board of Trustees of Lewis and Clark College, the National Advisory Board of the University of Michigan and Industrial Committees advising Stanford University and the University of Florida.

Dr. Rhines holds a Bachelor of Science degree in engineering from the University of Michigan, a Master of Science and PhD in materials science and engineering from Stanford University, a master of Business Administration from Southern Methodist University and Honorary Doctor of Technology degrees from the University of Florida and Nottingham Trent University.

... read more

Dr. Walden “Wally” Rhines

President & CEO
Cornami

WALDEN C. RHINES is President & CEO of Cornami. He is also CEO Emeritus of Mentor, a Siemens business, focusing on external communications and customer relations. He was previously CEO of Mentor Graphics for 23 years and Chairman of the Board for 17 years. During his tenure at Mentor, revenue nearly quadrupled and market value of the company increased 10X.

Prior to joining Mentor Graphics, Dr. Rhines was Executive Vice President, Semiconductor Group, responsible for TI’s worldwide semiconductor business. During his 21 years at TI, he was President of the Data Systems Group and held numerous other semiconductor executive management positions.

Dr. Rhines has served on the boards of Cirrus Logic, QORVO, TriQuint Semiconductor, Global Logic and as Chairman of the Electronic Design Automation Consortium (five two-year terms) and is currently a director. He is also a board member of the Semiconductor Research Corporation and First Growth Children & Family Charities. He is a Lifetime Fellow of the IEEE and has served on the Board of Trustees of Lewis and Clark College, the National Advisory Board of the University of Michigan and Industrial Committees advising Stanford University and the University of Florida.

Dr. Rhines holds a Bachelor of Science degree in engineering from the University of Michigan, a Master of Science and PhD in materials science and engineering from Stanford University, a master of Business Administration from Southern Methodist University and Honorary Doctor of Technology degrees from the University of Florida and Nottingham Trent University.

 

Ken Mandal

Chief Product Research Officer
Sparkflows

Ken Mandal

Chief Product Research Officer
Sparkflows

Ken Mandal

Chief Product Research Officer
Sparkflows
 

Simon Leedham

Professor of Molecular and Population Genetics/ Honorary Consultant Gastroenterologist
University of Oxford/ John Radcliffe Hospital

Simon Leedham is Professor of Molecular and Population Genetics University of Oxford and an Honorary Consultant Gastroenterologist at the John Radcliffe Hospital.

Read full bio

Simon Leedham

Professor of Molecular and Population Genetics/ Honorary Consultant Gastroenterologist
University of Oxford/ John Radcliffe Hospital

Simon Leedham

Professor of Molecular and Population Genetics/ Honorary Consultant Gastroenterologist
University of Oxford/ John Radcliffe Hospital

Simon Leedham is Professor of Molecular and Population Genetics University of Oxford and an Honorary Consultant Gastroenterologist at the John Radcliffe Hospital. His research is into the morphogenic signalling pathways that control the intestinal stem cell in homeostasis, regeneration and cancer, and he has published more than 90 peer reviewed papers in journals that include Nature Medicine, Nature Genetics, Cell Stem Cell, Gastroenterology and Gut. Simon’s research has been recognised by the United European Gastroenterology Rising Star award in 2010, the British Society of Gastroenterology Francis Avery Jones research prize in 2015 and the CRUK future leaders prize in 2017. Simon’s clinical work involves the care of patients with familial predisposition towards gastrointestinal cancer and he is Associate Director of the Oxford Centre for Cancer Early Detection.

 

Rik Bryan

Professor in Urothelial Cancer Research
University of Birmingham

Rik Bryan is the Director of The Bladder Cancer Research Centre at the University of Birmingham and Professor in Urothelial Cancer Research. He is a former clinical urologist who became a full-time bladder cancer research academic in 2009, subsequently establishing a dedicated bladder cancer research laboratory group at the University of Birmingham. Initially focusing on urinary biomarkers and proteomics, the team expanded to incorporate genomics & bioinformatics, novel therapeutics, and bio-medical engineering, all within an ethos of translation and clinical research.

Read full bio

Rik Bryan

Professor in Urothelial Cancer Research
University of Birmingham

Rik Bryan

Professor in Urothelial Cancer Research
University of Birmingham

Rik Bryan is the Director of The Bladder Cancer Research Centre at the University of Birmingham and Professor in Urothelial Cancer Research. He is a former clinical urologist who became a full-time bladder cancer research academic in 2009, subsequently establishing a dedicated bladder cancer research laboratory group at the University of Birmingham. Initially focusing on urinary biomarkers and proteomics, the team expanded to incorporate genomics & bioinformatics, novel therapeutics, and bio-medical engineering, all within an ethos of translation and clinical research.

 

Jill Walker

Head Early Disease Detection Diagnostics, Oncology Precision Medicine
AstraZeneca

Jill is an experienced Scientist (BSc, PHD) with over 20yr experience in Oncology Pharma. As the current Head of Early-Stage Disease Diagnostics, Jill has a key role in delivering the AZ strategy to intercept disease early using novel technologies as the next generation of diagnostics.

Read full bio

Jill Walker

Head Early Disease Detection Diagnostics, Oncology Precision Medicine
AstraZeneca

Jill Walker

Head Early Disease Detection Diagnostics, Oncology Precision Medicine
AstraZeneca

Jill is an experienced Scientist (BSc, PHD) with over 20yr experience in Oncology Pharma. As the current Head of Early-Stage Disease Diagnostics, Jill has a key role in delivering the AZ strategy to intercept disease early using novel technologies as the next generation of diagnostics. Building on her experience devising and leading the AZ IO and ADC Diagnostic strategies Jill has first-hand, practical experience of working in all stage of clinical development, building innovative regulatory strategies to secure drug and diagnostic approval and establishing effective Cross-Industry collaborations to meet the needs of patients living with Cancer.

 

Dr Gwen Murphy

Deputy Chair Upper Gastrointestinal Group/ Senior Research Fellow
National Cancer Research Institute/ Imperial College London

Dr Gwen Murphy earned a PhD in Clinical Medicine from Trinity College Dublin, Ireland, in 2005, and a Masters in Public Health from University College Dublin in 2006. Dr Murphy joined DCEG as an NCI Cancer Prevention Fellow within the Infections and Immunoepidemiology Branch in 2006, where she worked with Dr Charles Rabkin to initiate the NCI International EBV-Gastric Cancer Consortium. During her fellowship she also collaborated with Dr Amanda Cross on a suite of molecular epidemiology studies within the Polyp Prevention Trial.

Read full bio

Dr Gwen Murphy

Deputy Chair Upper Gastrointestinal Group/ Senior Research Fellow
National Cancer Research Institute/ Imperial College London

Dr Gwen Murphy

Deputy Chair Upper Gastrointestinal Group/ Senior Research Fellow
National Cancer Research Institute/ Imperial College London

Dr Gwen Murphy earned a PhD in Clinical Medicine from Trinity College Dublin, Ireland, in 2005, and a Masters in Public Health from University College Dublin in 2006. Dr Murphy joined DCEG as an NCI Cancer Prevention Fellow within the Infections and Immunoepidemiology Branch in 2006, where she worked with Dr Charles Rabkin to initiate the NCI International EBV-Gastric Cancer Consortium. During her fellowship she also collaborated with Dr Amanda Cross on a suite of molecular epidemiology studies within the Polyp Prevention Trial. In 2009, Dr Murphy moved to the Nutritional Epidemiology Branch as a Research Fellow, becoming a Staff Scientist in 2012.